Back

Extracellular vesicle subtypes for therapeutic application: challenges to overcome

12 April 2024 (16:30 - 16:45)
Organised by: Logo
Congress Presentation Part of: Targeted delivery of therapeutic agents to the heart - challenges and perspectives Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Professor Joost Sluijter

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Virus-mediated gene transfer to induce cardiac repair: where do we stand?
Associate Professor M. Gladka (Amsterdam, NL)
Slides
Presentation thumbnail
Utilisation and potential of RNA-based therapies in cardiovascular disease
Doctor S. Ounzain (Lausanne, CH)
Slides
Presentation thumbnail
Dissecting signal transduction pathways that regulate cardiomyocyte proliferation
Miss R. Artioli (Trieste, IT)
Abstract Slides

Access the full session

Session thumbnail
Targeted delivery of therapeutic agents to the heart - challenges and perspectives

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 16:30 CET
You may be interested in
thumbnail
Webinar
Exosomes - what are they and how can they benefit in ischaemic heart disease?
23 February 2021
thumbnail
Practice Tools
How to measure microparticles in prevention and rehabilitation
5 November 2018
thumbnail
Congress Presentation
Exploring in vitro markers of potency of extracellular vesicles from cardiosphere-derived cells in the treatment of cardiac ageing
26 August 2022
thumbnail
Congress Presentation
Serum exosomal microRNAs in patients with heart failure are correlated with myocardial DNA damage and future reverse remodeling
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources